AlphaCore Capital LLC Has $2.55 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Key Points

• AlphaCore Capital LLC significantly increased its stake in UnitedHealth Group by 652.2%, bringing its total holdings to $2.55 million by acquiring 4,220 additional shares during the first quarter.
• The company recently reported an EPS of $4.08, missing analysts' estimates of $4.45, while its revenue was $111.62 billion, reflecting a 12.9% year-over-year increase.
• UnitedHealth Group announced a quarterly dividend of $2.21 per share, increasing its annual dividend yield to 3.6%, up from the previous quarter's $2.10.

AlphaCore Capital LLC increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 652.2% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,867 shares of the healthcare conglomerate's stock after acquiring an additional 4,220 shares during the quarter. AlphaCore Capital LLC's holdings in UnitedHealth Group were worth $2,549,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of UNH. Mitsubishi UFJ Asset Management Co. Ltd. raised its position in shares of UnitedHealth Group by 11.7% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 3,059,712 shares of the healthcare conglomerate's stock valued at $1,602,520,000 after buying an additional 319,640 shares during the last quarter. Alesco Advisors LLC lifted its position in shares of UnitedHealth Group by 6.2% in the 1st quarter. Alesco Advisors LLC now owns 562 shares of the healthcare conglomerate's stock worth $294,000 after acquiring an additional 33 shares during the period. Keb Asset Management LLC acquired a new stake in shares of UnitedHealth Group during the 1st quarter worth approximately $1,013,000. Waycross Partners LLC raised its stake in shares of UnitedHealth Group by 21.6% in the first quarter. Waycross Partners LLC now owns 33,795 shares of the healthcare conglomerate's stock valued at $17,700,000 after purchasing an additional 6,001 shares in the last quarter. Finally, Deutsche Bank AG increased its holdings in UnitedHealth Group by 2.0% in the 1st quarter. Deutsche Bank AG now owns 5,386,274 shares of the healthcare conglomerate's stock valued at $2,821,061,000 after buying an additional 103,160 shares during the period. 87.86% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several brokerages have recently weighed in on UNH. Truist Financial decreased their target price on shares of UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating on the stock in a research report on Wednesday, July 16th. Royal Bank Of Canada lowered their price objective on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 30th. Wells Fargo & Company cut their target price on UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating for the company in a research report on Monday. Mizuho dropped their price objective on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a research note on Friday, May 16th. Finally, TD Securities reaffirmed a "hold" rating and issued a $308.00 target price (down previously from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $366.52.

UnitedHealth Group Stock Down 0.6%

NYSE:UNH opened at $244.42 on Friday. The stock's fifty day moving average price is $292.78 and its two-hundred day moving average price is $408.71. The company has a market cap of $221.72 billion, a price-to-earnings ratio of 10.59, a P/E/G ratio of 1.59 and a beta of 0.43. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The firm had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the previous year, the business earned $6.80 earnings per share. UnitedHealth Group's revenue for the quarter was up 12.9% compared to the same quarter last year. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.6%. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group's payout ratio is presently 38.30%.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Stephen J. Hemsley bought 86,700 shares of the firm's stock in a transaction dated Friday, May 16th. The stock was bought at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the transaction, the chief executive officer owned 679,493 shares of the company's stock, valued at $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Kristen Gil acquired 3,700 shares of the firm's stock in a transaction that occurred on Thursday, May 15th. The shares were purchased at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the acquisition, the director owned 3,818 shares of the company's stock, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Insiders acquired 109,408 shares of company stock valued at $31,607,768 over the last quarter. 0.28% of the stock is owned by corporate insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.